NRx Pharmaceuticals (NRXP)
(Delayed Data from NSDQ)
$3.54 USD
+0.40 (12.74%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $3.75 +0.21 (5.93%) 7:58 PM ET
3-Hold of 5 3
F Value A Growth F Momentum D VGM
Price, Consensus and EPS Surprise
NRXP 3.54 +0.40(12.74%)
Will NRXP be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for NRXP based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for NRXP
NRx Pharmaceuticals, Inc. (NRXP) Advances While Market Declines: Some Information for Investors
NRx Pharmaceuticals, Inc. (NRXP) Advances While Market Declines: Some Information for Investors
NRXP: What are Zacks experts saying now?
Zacks Private Portfolio Services
NRx Pharmaceuticals (NRXP) Upgraded to Strong Buy: Here's What You Should Know
New Strong Buy Stocks for April 4th
Pick These Top-Ranked Stocks to Deck Up Your Christmas Tree
Other News for NRXP
CGC, GENE and HOLO among mid-day movers
12 Health Care Stocks Moving In Thursday's Intraday Session
Crude Oil Edges Lower; Bio-Path Holdings Shares Spike Higher
Why Las Vegas Sands Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Why Is Bio-Path (BPTH) Stock Up 89% Today?